Fig. 2From: Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myelomaVolcano plot showing effects of human plasma proteins on the risk of multiple myeloma. Data are expressed as odds ratios (OR) estimated by the inverse variance-weighted (IVW) method. The red dots represent the plasma proteins was significant positively associated with the risk of multiple myeloma (PFDR < 0.05). The blue dots represent the plasma proteins significant was inversely associated with the risk of multiple myeloma (PFDR < 0.05). The black dashed line represents the association threshold of FDR corrected P-value < 0.05. C1QC, complement C1q subcomponent subunit C; CBR1, carbonyl reductase 1; FCGR3B, Fc-gamma receptor III-B; FSTL1, follistatin-related protein 1; FDR, false discovery rate; GPC1, glypican 1; GZMB, granzyme B; NAMPT, nicotinamide phosphoribosyl transferase; NCF2, neutrophil cytosol factor 2; PAFAH1B2, platelet-activating factor acetyl hydrolase IB subunit beta; PDE4D, cAMP-specific 3',5'-cyclic phosphodiesterase 4D; PTPN4, protein tyrosine phosphatase non-receptor type 4; SOCS3, suppressor of cytokine signaling 3; TIE1, Tyrosine kinase with immunoglobulin-like and EGF-like domains 1; SNP, single nucleotide polymorphismBack to article page